Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Alcon, officially known as Alcon Inc., is a leading global provider of specialised medical, optical, and precision instruments, with its headquarters situated in Switzerland. Established in 1945, the company has grown to become a prominent player in the healthcare industry, particularly within the fields of ophthalmology and vision care.
Alcon’s core offerings include innovative eye care products such as surgical equipment, contact lenses, and intraocular lenses, distinguished by their advanced technology and high quality. The company operates across major regions worldwide, serving healthcare professionals and patients alike. Recognised for its significant contributions to eye health, Alcon maintains a strong market position through continuous innovation and a commitment to improving visual outcomes globally.
+13 vs industry average
Alcon’s score of 45 is higher than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medical Device Manufacturing has below-average carbon intensity
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Scope 3 accounts for ••• of total emissions.
Alcon, headquartered in Switzerland and operating in the Medical, precision and optical instruments, watches and clocks industry, reported total market-based Scope 1 and 2 emissions of 200,199,000 kg CO2e in 2025. This includes 78,239,000 kg CO2e from Scope 1 and 121,960,000 kg CO2e from market-based Scope 2 emissions. Their Scope 3 emissions for 2025 were 1,195,537,000 kg CO2e.
Looking back, in 2024, Alcon's market-based Scope 1 and 2 emissions were 204,978,000 kg CO2e, comprising 74,202,000 kg CO2e from Scope 1 and 130,776,000 kg CO2e from market-based Scope 2. In 2023, these figures were 233,482,000 kg CO2e for market-based Scope 1 and 2, with 75,183,000 kg CO2e from Scope 1 and 158,299,000 kg CO2e from market-based Scope 2. The company disclosed Scope 1 and 2 emissions for earlier years but did not consistently disclose Scope 3 data.
Alcon has committed to achieving carbon neutrality across its global operations (Scope 1 and Scope 2 emissions) by 2030. For Scope 3 emissions, which represent a significant portion of their total GHG emissions, Alcon aspires to establish reduction targets for both 2040 and 2050, aligning with Swiss climate disclosures. Their short-term goal for Scope 3 is to refine emissions data for key categories such as purchased goods and services, and upstream transportation and distribution.
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more